Herbalife Analyst Ratings
Herbalife Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/14/2023 | -7.47% | DA Davidson | → $13.5 | Initiates Coverage On | → Neutral |
| 08/03/2023 | 16.52% | Mizuho | $13 → $17 | Maintains | Neutral |
| 06/07/2023 | -10.9% | Mizuho | → $13 | Initiates Coverage On | → Neutral |
| 03/01/2023 | 91.91% | Citigroup | $26 → $28 | Maintains | Buy |
| 02/03/2023 | -4.04% | B of A Securities | → $14 | Initiates Coverage On | → Underperform |
| 11/01/2022 | 112.47% | B. Riley Securities | $38 → $31 | Maintains | Buy |
| 11/01/2022 | 78.2% | Citigroup | $30 → $26 | Maintains | Buy |
| 10/05/2022 | 105.62% | Citigroup | $36 → $30 | Maintains | Buy |
| 07/12/2022 | — | Jefferies | Upgrades | Hold → Buy | |
| 05/17/2022 | — | Argus Research | Downgrades | Buy → Hold | |
| 05/04/2022 | 181.01% | B. Riley Securities | $50 → $41 | Maintains | Buy |
| 05/04/2022 | 146.74% | Citigroup | $46 → $36 | Maintains | Buy |
| 05/04/2022 | 78.2% | Jefferies | $60 → $26 | Downgrades | Buy → Hold |
| 09/16/2021 | 256.41% | Citigroup | $57 → $52 | Maintains | Buy |
| 06/29/2021 | 379.78% | B. Riley Securities | → $70 | Initiates Coverage On | → Buy |
| 05/08/2020 | 283.82% | Citigroup | $49 → $56 | Maintains | Buy |
| 02/20/2020 | 235.85% | Citigroup | $55 → $49 | Maintains | Buy |
| 12/04/2019 | 276.97% | Citigroup | → $55 | Assumes | → Buy |
| 08/02/2019 | 290.68% | Citigroup | $66 → $57 | Maintains | Buy |
| 10/11/2018 | 345.51% | Jefferies | → $65 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/14/2023 | -7.47% | 達·戴維森 | →$13.5 | 開始承保 | →中性 |
| 08/03/2023 | 16.52% | 瑞穗 | $13→$17 | 維護 | 中性 |
| 06/07/2023 | -10.9% | 瑞穗 | →$13 | 開始承保 | →中性 |
| 03/01/2023 | 91.91% | 花旗集團 | $26→$28 | 維護 | 買 |
| 02/03/2023 | -4.04% | B of A證券 | →$14 | 開始承保 | →表現不佳 |
| 11/01/2022 | 112.47% | B.萊利證券 | $38→$31 | 維護 | 買 |
| 11/01/2022 | 78.2% | 花旗集團 | $30→$26 | 維護 | 買 |
| 10/05/2022 | 105.62% | 花旗集團 | $36→$30 | 維護 | 買 |
| 07/12/2022 | - | 傑富瑞 | 升級 | 持有→購買 | |
| 2022/05/17 | - | Argus研究 | 評級下調 | 購買→Hold | |
| 05/04/2022 | 181.01% | B.萊利證券 | $50→$41 | 維護 | 買 |
| 05/04/2022 | 146.74% | 花旗集團 | $46→$36 | 維護 | 買 |
| 05/04/2022 | 78.2% | 傑富瑞 | $60→$26 | 評級下調 | 購買→Hold |
| 09/16/2021 | 256.41% | 花旗集團 | $57→$52 | 維護 | 買 |
| 2021/06/29 | 379.78% | B.萊利證券 | →$70 | 開始承保 | →購買 |
| 05/08/2020 | 283.82% | 花旗集團 | $49→$56 | 維護 | 買 |
| 02/20/2020 | 235.85% | 花旗集團 | $55→$49 | 維護 | 買 |
| 2019/12/04 | 276.97% | 花旗集團 | →$55 | 假設 | →購買 |
| 2019年08月02日 | 290.68% | 花旗集團 | $66→$57 | 維護 | 買 |
| 2018年10月11日 | 345.51% | 傑富瑞 | →$65 | 開始承保 | →購買 |
What is the target price for Herbalife (HLF)?
康寶萊(Herbalife)的目標價是多少？
The latest price target for Herbalife (NYSE: HLF) was reported by DA Davidson on September 14, 2023. The analyst firm set a price target for $13.50 expecting HLF to fall to within 12 months (a possible -7.47% downside). 8 analyst firms have reported ratings in the last year.
DA Davidson於2023年9月14日報道了康寶萊(紐約證券交易所代碼：HLF)的最新目標價。這家分析公司將目標價定為13.50美元，預計HLF將在12個月內跌至(可能下跌7.47%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Herbalife (HLF)?
康寶萊(Herbalife)最新的分析師評級是多少？
The latest analyst rating for Herbalife (NYSE: HLF) was provided by DA Davidson, and Herbalife initiated their neutral rating.
康寶萊(紐約證券交易所股票代碼：HLF)的最新分析師評級由DA Davidson提供，康寶萊開始對其進行中性評級。
When is the next analyst rating going to be posted or updated for Herbalife (HLF)?
康寶萊(Herbalife)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Herbalife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Herbalife was filed on September 14, 2023 so you should expect the next rating to be made available sometime around September 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與康寶萊的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。康寶萊的上一次評級是在2023年9月14日提交的，因此你應該預計下一次評級將在2024年9月14日左右公佈。
Is the Analyst Rating Herbalife (HLF) correct?
分析師對康寶萊(Herbalife)的評級正確嗎？
While ratings are subjective and will change, the latest Herbalife (HLF) rating was a initiated with a price target of $0.00 to $13.50. The current price Herbalife (HLF) is trading at is $14.59, which is out of the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的康寶萊(HLF)評級是以0.00美元至13.50美元的目標價啟動的。康寶萊目前的股價為14.59美元，超出了分析師的預期區間。